Download this White Paper
As life science companies encounter ever-evolving challenges to get their new products to global markets – lagging COVID-19 related supply chain setbacks, increased regulation, and worldwide inflation uncertainty, to name a few – they are increasingly turning to outsourcing and onshoring as solutions.
Cambrex, in partnership with Citeline, recently surveyed 100 industry leaders to see how they are using the capabilities of contract development and manufacturing organizations (CDMOs) and onshoring to advance their development processes.
Download the whitepaper to:
Offered Free by: Cambrex Corporation
See All Resources from: Cambrex Corporation